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Type VI secretion systems (T6SS) have been studied primarily in the context of pathogenic bacteria-host
interactions. Recent data suggest, however, that these versatile secretion systems may also function to
promote commensal or mutualistic relationships between bacteria and eukaryotes or tomediate cooperative
or competitive interactions between bacteria.Introduction
The type VI secretion system (T6SS) was recognized as a distinct
class of bacterial protein secretion system in 2006 with two
papers from the Mekalanos laboratory. The first study (Pukatzki
et al., 2006) found that the IcmF-associated homologous protein
(IAHP) gene cluster of Vibrio cholerae was required for secretion
of the proteins Hcp and VgrG and for cytotoxicity toward Dic-
tyostelium amoebae. The second study (Mougous et al., 2006)
included structural data that indicated the formation of a secre-
tion apparatus and provided evidence that the apparatus was
functional during chronic lung infection of Pseudomonas aerugi-
nosa in cystic fibrosis patients. Both studies described type VI
secretion (T6S) in the context of pathogenesis—indeed, the
T6SS-encoding genes of V. cholerae were named virulence-
associated secretion (vas) genes.
Putative T6SS-encoding gene clusters have now been identi-
fied in over one-fourth of sequenced Gram-negative bacterial
genomes (Bingle et al., 2008; Persson et al., 2009; Pukatzki
et al., 2009). Many of these T6SS-containing bacteria are known
pathogens, and T6SS have been experimentally shown to play
a role in virulence in several cases (see Bingle et al., 2008 and
Pukatzki et al., 2009 for specific references). In Burkholderia
mallei, T6S is required for virulence in a hamster model and
promotes giant multinucleated cell formation and intracellular
spread in macrophage cell lines (Burtnick et al., 2010). In Bur-
kholderia cenocepacia, Hcp is required for host cell actin remod-
eling and confers resistance to predation by Dictyostelium
amoebae, and Tn insertions in T6SS-encoding genes were asso-
ciated with virulence defects in in vivo chronic lung infection
models. Deletion of genes encoding T6SS components in
Edwardsiella tarda caused a virulence defect in a blue gourami
fish host. And when produced inside HeLa cells, Hcp of Aeromo-
nas hydrophila induced apoptosis and T6S contributed to
virulence of this pathogen in mice. In some cases, putative
T6SS components contribute to virulence, but in a manner that
appears to be independent of other T6SS components. In Agro-
bacterium tumefaciens, for example, Hcp appeared to con-
tribute to tumorigenesis of potato tuber disks, but deletion of
the rest of the T6SS-encoding genes had no effect. Similarly,
homologs of T6SS-encoding genes in Francisella tularensis
were required for growth within macrophages and virulence
in mice, but the secretion of those gene products appeared
not to require the other putative T6SS-encoding genes2 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.(Barker et al., 2009). The Agrobacterium and Francisella studies
highlight the need for a better understanding of what exactly
constitutes a T6SS and how T6SS and their effectors function
mechanistically.
The importance of T6S in pathogenesis is becoming increas-
ingly clear. However, many bacteria with genomes encoding
putative T6SS are not known to be pathogens or even symbi-
onts, suggesting T6S may also function in nonpathogenic
bacteria-host interactions or in interactions not involving eukary-
otic partners. Several papers, including three published in Cell
Host & Microbe in the last year, highlight the potential diversity
of functions for T6S.
T6SS as Virulence Factors
Understanding the mechanisms underlying T6S and its role in
pathogenesis has been challenging because of the lack of iden-
tified effector proteins. Although in vitro studies identified two
proteins that were secreted in a T6SS-depndent manner, Hcp
and VgrG, each was required for the secretion of the other, sug-
gesting that both might be part of the secretion apparatus and
not bona fide effectors. V. cholerae produces three VgrG pro-
teins, VgrG-1, VgrG-2, and VgrG-3. These proteins share a
conserved N-terminal domain but contain divergent C termini.
The C-terminal domain of VgrG-1 has predicted similarity to
the actin crosslinking domain (ACD) of RtxA, a large RTX-con-
taining toxin of V. cholerae. Incubation of purified recombinant
VgrG-1 with eukaryotic cell lysates showed that VgrG-1 cross-
links actin, and incubation of J774 cells with various T6SS
mutant and parental V. cholerae strains showed that VgrG-1
and other core T6SS components (VasK and Hcp) were neces-
sary to induce actin crosslinking in host cells (Pukatzki et al.,
2007). These data suggested an actin crosslinking effector func-
tion for VgrG-1, but the requirement of VgrG-1 for secretion
confounded its classification as an effector.
Ma et al. (2009) aimed to disentangle the effector and secre-
tory functions of VgrG-1 by comparing V. cholerae strains that
contained deletions of either the entire vgrG-1 gene or only the
region encoding the C-terminal ACD. Their data showed that
the ACD was required for actin crosslinking and cytotoxicity
toward J774 cells andDictyostelium but not for T6SS-dependent
protein secretion. To determine if the ACD was translocated into
host cells, J774 cells were infected with V. cholerae strains con-
taining a b-lactamase reporter fused to or replacing the ACD of
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long as the N-terminal portion of VgrG-1 and known core T6SS
components were intact. Together, these data indicated that
the conserved N-terminal portion of VgrG-1 is part of the secre-
tion system proper, while the C-terminal ACD functions as an
effector. This work was the first to definitively and specifically
identify a T6S effector. Interestingly, previous work had noted
that several other bacteria encode VgrG orthologs containing
divergent C-terminal extensions with diverse predicted functions
(Pukatzki et al., 2007). Whether these orthologs represent true
effectors and what their specific functions are remain to be
determined. Identification of additional effectors, their targets
and mechanisms of action, and their conservation among
T6SS of different bacteria will be important for understanding
the role of T6S in pathogenesis and other types of interactions.
The second important finding to come out of the Ma et al.
(2009) study was that T6S only occurs after the bacteria
are internalized and that VgrG-1-mediated actin crosslinking
inhibits further phagocytic activity. While studies of other
bacteria, including Burkholderia pseudomallei, B. cenocepacia,
and Salmonella enterica serovar Typhimurium (S. Typhimurium),
had also found that expression of T6SS-encoding genes was
induced upon uptake into host cells, the resulting impairment
of further phagocytic activity indicated by the Ma et al. study
was an important new finding. The authors hypothesized that
actin crosslinking and resultant inhibition of phagocytosis by
early-colonizing bacteria may protect additional ‘‘bystander’’ or
late-colonizing bacteria from phagocytosis, i.e., that T6S may
mediate altruistic behavior among bacteria—an intriguing idea.
Having shown that translocation of the VgrG-1 ACD requires
endocytosis and results in actin crosslinking in host cells
in vitro, Ma and Mekalanos went on to investigate the mecha-
nism of action of VgrG-1 and the T6SS in vivo. They first com-
pared fluid accumulation and gene expression in the intestines
of mice infected with various T6SS mutant and rtxA deletion
strains (Ma and Mekalanos, 2010). (In both Ma et al., [2009]
and Ma and Mekalanos, [2010], parental strains were DhlyAD
hapA, since these genes encode accessory toxins that would
mask effects of T6S on mammalian cells. In some cases, rtxA
was also deleted to avoid confounding results, since RtxA also
crosslinks actin.) Fluid accumulation and monocyte infiltration
in the intestinal lumen and expression of several inflammation-
associated genes were decreased in the T6SS mutant-infected
mice compared with those infected with parental strains. These
phenotypes required not only the core components of the T6SS,
but also the ACD of VgrG-1, providing in vivo evidence for the
effector function of the ACD. In addition, crosslinked actin was
detected in intestines of mice infected with parental strains,
but not those infected with strains carrying deletions in any of
the T6SS-encoding genes tested. Together, these results
suggest that the ACD of VgrG-1 is translocated into and cross-
links actin in host cells in vivo and that this activity leads to
inflammation and pathology in the intestines of mice. Ma and
Mekalanos took their study a step further to test the hypothesis
that early-colonizing bacteria use their T6SS to facilitate coloni-
zation by late-colonizing bacteria. They first ‘‘preinfected’’ mice
with bacteria producing either wild-type VgrG-1 or DACD
VgrG-1 then ‘‘superinfected’’ 4 hr later with either the same or
the opposite strain. They found that preinfection with bacteriaproducing wild-type VgrG-1, but not with bacteria producing
DACD VgrG-1, allowed superinfected DACD VgrG-1-producing
bacteria to grow in the mouse intestines to levels indistinguish-
able from that of wild-type VgrG-1-producing bacteria. The
data suggest that initial infection by wild-type VgrG-1-producing
bacteria creates a favorable within-host environment for the
growth of V. cholerae. Whether this environment is favorable
because the phagocytic cells have been inactivated or because
of some other aspect of the VgrG-1-dependent altered inflam-
matory response remains to be determined. Nonetheless, the
results suggest that the V. cholerae T6SSmay function as a viru-
lence factor in both the immediate sense of causing inflammation
and in a longer-term, or ultimate, sense of contributing to within-
host growth and probably subsequent transmission.
It is worth noting that the use ofDictyostelium to study V. chol-
erae pathogenesis was pivotal to the discovery of T6S as a new
class of secretion system with a role in virulence. The use of
invertebrate models for mimicking human infection processes
has been variably successful and a topic of debate. For patho-
gens with environmental habitats, however, it is likely that
some virulence factors used for human infection evolved from
and/or still function as factors important during interactions
with diverse organisms that facilitate environmental survival
(Matz and Kjelleberg, 2005; Matz et al., 2008). For V. cholerae,
a role for T6S during interactions with environmental amoeba
seems likely based on the clear, measurable phenotype of the
T6S mutant in Dictyostelium. The importance of T6S during
infection of mammals by V. cholerae is less obvious and may
have been missed completely if not for the use of Dictyostelium,
since T6S-dependent phenotypes in mammalian hosts or cell
lines require the use of V. cholerae strains with deletions in genes
encoding accessory toxins (hlyA, hapA, and/or rtxA). As with
V. cholerae, many other T6SS-possessing bacterial species
can be found free-living in the environment or in association
with nonmammalian hosts. While many of these bacteria are
studiedmost intensively due to their potential as facultative path-
ogens of humans, awareness of their environmental interactions
as part of the disease cycle is important and rising. For example,
it is clear that understanding the interaction between Yersinia
pestis and fleas is critical to understanding how this pathogen
causes plague in humans. B. pseudomallei, a soil saprotroph,
is being studied in amoeba, nematodes, a larval insect, and
tomato plants with the hope that understanding these interac-
tions will shed light on the mechanisms it uses to cause human
melioidosis. Although some factors may be host specific, it
seems likely that others are not, and their discovery may be facil-
itated by the use of nonmammalian models.
T6SS as Antipathogenesis Factors
While several studies support a role for T6S in pathogenesis,
a few support an alternate view: that T6S may function to limit
bacterial replication or virulence, pushing interactions with hosts
away from pathogenesis and toward a commensal or mutualistic
state. In fact, one of the first T6SS mutants characterized was
one involved in a mutualistic relationship. Rhizobium legumino-
sarum colonizes the roots of leguminous plants, forming nodules
in which it fixes nitrogen. The Rhizobium-plant interaction is
highly specific, and certain variants of R. leguminosarum form
nitrogen-fixing nodules only with plants in the clover group.Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 3
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tion in the imp gene cluster (now known to encode a T6SS) was
also able to form functional nitrogen-fixing nodules on pea
plants. Their data indicated that the imp gene cluster (i.e., the
T6SS) was involved in secretion of proteins that block infection
of pea plants by R. leguminosarum, thus determining host spec-
ificity of the Rhizobium-plant interaction. Another example of an
antipathogenesis role for the T6SS comes from studies with
S. Typhimurium. Parsons and Heffron (2005) identified a locus,
sciS (now known to encode part of a T6SS), which whenmutated
results in increased replication of S. Typhimurium in macro-
phages at 24 hr postinoculation and increased virulence in
a mouse model, suggesting the role of sciS, and hence T6SS,
in S. Typhimurium is to limit virulence and therefore contribute
to long-term colonization.
A recent study of Helicobacter hepaticus further indicates that
T6S can function to limit within-host growth and virulence.
H. hepaticus is a common symbiont and possible facultative
pathogen of rodent gastrointestinal tracts. Using confocal
microscopy and gentamicin protection assays, Chow and Maz-
manian (2010) showed that H. hepaticus adherence to and inter-
nalization by mouse intestinal epithelial cell (IEC) lines was
increased for a T6SSmutant compared with the wild-type strain.
Furthermore, colonization of mouse colon and invasion of IECs
in vivo, as determined by 16S quantitative PCR of colon tissue
and bacterial cfu counts from gentamicin-treated purified IECs,
were increased in the T6SS mutant. Chow and Mazmanian
then asked whether the T6SS could reduce the inflammation
caused byH. hepaticus under experimentally induced dysbiosis.
They defined dysbiosis as an imbalance in the composition of the
host-associated microbiota, which can cause some symbiotic
bacteria to have pathogenic effects. To produce a model of dys-
biosis, they reconstituted T and B cell-deficient mice with naive
CD4+CD45Rb high T cells (i.e., T cells from germ-free mice,
such that they have not been exposed to bacterial antigens).
These T cells react pathogenically to certain gut bacteria, includ-
ing H. hepaticus, whereas ‘‘experienced’’ T cells from mice with
normal gut microbiota tolerate these bacteria. In this dysbiosis
model, the T6SS mutant showed higher colonization and
induced a stronger inflammatory response compared with
wild-type H. hepaticus. The authors concluded that the T6SS
functions to limit inflammation caused by H. hepaticus, thus
possibly reducing negative impacts of dysbiosis on the host.
The data presented by Chow and Mazmanian are compelling.
Important next steps include the identification of effectors
involved in limiting pathogenesis or mediating mutualism, since
the T6S-dependent translocation of effectors into host cells
has so far only been explicitly demonstrated in pathogenic inter-
actions. Identification of effectors involved in nonpathogenic
interactions will also help determine if the nature of a T6SS-medi-
ated interaction, whether antagonistic or beneficial, is dictated
by effectors specific to different types of interactions, or alterna-
tively, whether orthologous effectors in different bacteria can
mediate both positive and negative interactions. A greatermech-
anistic understanding would help distinguish whether patho-
genic versus nonpathogenic effects result from fundamentally
different interactions at the molecular level or are simply a result
of differences in the number of bacteria present within a host. For
example, in the H. hepaticus system, does the T6SS prevent4 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.inflammation by altering host cell response to the presence of
the bacterium or simply by limiting the number of bacteria?
Differentiating between pathogenic and nonpathogenic inter-
actions can be complicated by the fact that the distinction is
often ambiguous and can depend on the context and time frame
of the interaction. Time frame can be particularly important, since
factors that reduce acute harm to a host, as seen for T6S in
S. Typhimurium, may in fact promote transmission by enabling
a latent sit-and-wait phase. Detection of these various effects
will depend on the design and scope of the study. The H. hepa-
ticus system illustrates the importance of ecological context,
since the pathological effects of the bacterium are dependent
on prior exposure of the host to gut microflora. For H. hepaticus,
translating differences in inflammation-associated gene expres-
sion to pathology will help elucidate how the T6SS of H. hepati-
cus ultimately maintains a nonpathogenic relationship with the
host. Studies incorporating both immediate and long-term
effects of T6S on hosts, as discussed for the Ma and Mekalanos
pathogenesis study above, will be important in further distin-
guishing antagonistic fromharmless ormutualistic effects of T6S.
T6SS in Interbacterial Interactions
New data present the intriguing possibility that T6S may function
to mediate interactions between bacteria rather than between
bacteria and their eukaryotic hosts. A review of Myxococcus
xanthus extracellular biology alluded to a role for T6S in the
formation of fruiting bodies, suggesting T6S may be used for
intraspecies microbial cooperation (Konovalova et al., 2010).
Alternatively, recent work by Hood et al. (2010) suggests that
T6SS may mediate antagonistic interactions between bacteria.
By comparing secretomes of Pseudomonas aeruginosa strains
with either disruption or constitutive overexpression of the H1-
T6SS gene cluster, the group identified three putative T6SS
effectors, which they named Tse1–3 (type six effector 1–3). All
three putative effectors were secreted into culture supernatants
in a manner requiring the presence of the core T6S components
Hcp1 and ClpV1 and deletion of genes encoding negative regu-
lators of H1-T6S (retS, which encodes a global regulator that
represses transcription of H1-T6SS genes, and/or pppA, which
encodes a serine-threonine phosphatase that posttranslationally
represses T6S). However, none of the tse genes was required for
the secretion of Hcp, indicating that they are not part of the
secretion apparatus and may function solely as effectors.
One of the putative effectors, Tse2, was toxic to yeast,
mammalian cells, and bacteria when produced intracellularly.
The inability to introduce a deletion mutation in a small open
reading frame immediately downstream of tse2 if tse2was intact
(but not if it was also deleted) caused the authors to suspect that
the downstream gene, which they named tsi2, encoded a protein
conferring immunity to the toxic effects of tse2. In support of this
hypothesis, Tsi2 interacted with Tse2 in coimmunoprecipitation
experiments, and production of Tsi2 within cells relieved toxicity
of Tse2 for both eukaryotes (yeast and mammalian cells) and
bacteria.
While intracellular production of Tse2 resulted in toxicity for
all cells tested, subsequent experiments exposing target cells
to tse2-expressing P. aeruginosa yielded a surprising result:
eukaryotic cells were unaffected. Thus, although Tse2 was
secreted by P. aeruginosa in a T6S-dependent manner, it
Figure 1. Multifunctionality of Type VI
Secretion
As highlighted by three papers published in the
last year in Cell Host & Microbe, type VI secretion
systems have been implicated in virulence,
commensalism or symbiosis, and interbacterial
competition.
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when P. aeruginosa was phagocytosed, suggesting that eukary-
otes are not the true target of the Tse2 effector. By contrast,
under certain culture conditions, the growth of bacterial target
cells lacking tse2/tsi2 was severely inhibited by coculture with
Tse2/Tsi2-expressing bacteria. Expression of tsi2 in the target
bacteria relieved the inhibition. Although Hood et al. did not
show that Tse2 was translocated into target bacteria, the data
suggest that Tse2 is a T6S effector that mediates competitive
interactions among bacteria.
The study by Hood et al., which used strains of P. aeruginosa
engineered to express their T6SS constitutively and in which
interbacterial inhibition occurred only when bacteria were grown
on a solid support, raises many questions. When and where
might the bacteria deploy their T6SS to inhibit the growth of
neighboring bacteria in nature? Do these systems mediate in
both intra- and interspecies inhibition? Can they distinguish
self from nonself target bacteria? Do T6SS encoded by other
bacteria function as interbacterial competition systems? If so,
do they have Tse2/Tsi2 orthologs with different specificities?
Do the T6SS that target bacteria (and therefore must translocate
proteins across two bacterial membranes) differ from those
that target eukaryotic cells (and therefore must translocate
proteins across only one plasma membrane)? Answering these
and other questions will be critical to gaining a complete under-
standing of T6SS and their potential.
T6SS as Mediators of Multiple Interactions in Diverse
Bacteria
The studies reviewed here showed that T6S functions in patho-
genesis in several bacteria, in antipathogenesis in a few others,Cell Host & Micrand in interbacterial interactions in a third
case (Figure 1). However, several bacte-
rial genomes contain multiple T6S-en-
coding gene clusters that appear not to
be paralogs, suggesting the possibility
for diverse functions. P. aeruginosa has
three predicted T6S-encoding gene
clusters, Y. pestis and Photorhabdus
luminescens each have four, and
B. mallei, B. thailandensis, and B. pseu-
domallei have four, five, and six, respec-
tively. Many bacteria with the potential
to produce several T6SS have multiple
hosts or survive in diverse environmental
conditions. Y. pestis interacts intimately
with both insects andmammals, and inci-
dentally, at least one of its T6SS is regu-
lated by changes in temperature compa-
rable to the body temperatures of fleasand mammals (Robinson et al., 2009). P. aeruginosa is both an
environmental microbe and facultative pathogen of humans
and can persist for years in the lungs of cystic fibrosis patients.
Similarly, B. pseudomallei is an environmental soil microbe and
facultative human pathogen, causing infections that reportedly
can persist for more than 60 years. Given the mounting evidence
for divergent functions of the T6SS, the idea that multiple T6SS
within individual bacterial species could mediate various types
of interactions with diverse hosts, predators, cooperators, or
competitors is an enticing possibility that demands further study.
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